Literature DB >> 4027991

International variations in epidemiology of cancers of the extrahepatic biliary tract.

B L Strom, P L Hibberd, K A Soper, P D Stolley, W L Nelson.   

Abstract

Previous studies of the descriptive epidemiology of biliary tract cancers have not differentiated among different types of biliary tract cancer because until recently the International Classification of Diseases (ICD) did not classify them separately. Recent versions of the ICD now distinguish cancers of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In order to describe more precisely the distribution of these three cancers, we obtained data from nine cancer registries throughout the world which used the eighth or ninth revision of the ICD. Sex-specific, age-adjusted disease rates were calculated for each disease. Log-linear models were used to evaluate the association of age and sex with the risk of acquiring each disease and to assess whether the risk of acquiring disease or the age and sex distribution of the three diseases varied by geographic location. Gallbladder cancer was the most common of the three diseases and occurred more frequently in females. Extrahepatic bile duct cancer was the next most common disease and occurred equally in both sexes. Cancer of the ampulla of Vater was the least common and was more common in males. The incidence of each of the diseases increased with age. The age and sex distributions of the different diseases different among the nine registries. Thus these three neoplasms differ in their descriptive epidemiology and should therefore be considered separately in clinical practice and in future investigations.

Entities:  

Mesh:

Year:  1985        PMID: 4027991

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.

Authors:  Halim Charbel; Firas H Al-Kawas
Journal:  Curr Gastroenterol Rep       Date:  2011-04

2.  C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.

Authors:  Thomas Gerhardt; Sabine Milz; Michael Schepke; Georg Feldmann; Martin Wolff; Tilman Sauerbruch; Franz Ludwig Dumoulin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

3.  Descriptive epidemiology of gall-bladder cancer in Europe.

Authors:  W Zatonskí; C La Vecchia; F Levi; E Negri; F Lucchini
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.

Authors:  Felipe A Castro; Jill Koshiol; Ann W Hsing; Susan S Devesa
Journal:  Int J Cancer       Date:  2013-04-11       Impact factor: 7.396

5.  Biliary tract cancers in Cote-d'Or (France): incidence and natural history.

Authors:  P Renard; M C Boutron; J Faivre; C Milan; L Bedenne; P Hillon; C Klepping
Journal:  J Epidemiol Community Health       Date:  1987-12       Impact factor: 3.710

6.  Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA).

Authors:  W H Chow; J K McLaughlin; H R Menck; T M Mack
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

7.  Morphologic analysis of digestive cancers from the registry of Vaud, Switzerland.

Authors:  F Levi; C La Vecchia; S Franceschi; V C Te
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

8.  Worldwide trends in mortality from biliary tract malignancies.

Authors:  Tushar Patel
Journal:  BMC Cancer       Date:  2002-05-03       Impact factor: 4.430

9.  Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.

Authors:  D Yoshikawa; H Ojima; M Iwasaki; N Hiraoka; T Kosuge; S Kasai; S Hirohashi; T Shibata
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.